AUROBINDO PHARMA
|
AUROBINDO PHARMA Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
Equity - Authorised | ₹179 Cr | ₹179 Cr | ₹66 Cr | ₹66 Cr | ₹66 Cr |
Equity - Issued | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
Equity Paid Up | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | - | - | - | ₹0.06 Cr |
Total Reserves | ₹26,781 Cr | ₹24,517 Cr | ₹21,871 Cr | ₹16,766 Cr | ₹13,832 Cr |
Securities Premium | ₹418 Cr | ₹418 Cr | ₹418 Cr | ₹418 Cr | ₹418 Cr |
Capital Reserves | ₹122 Cr | ₹82 Cr | ₹82 Cr | ₹82 Cr | ₹92 Cr |
Profit & Loss Account Balance | ₹24,013 Cr | ₹22,519 Cr | ₹20,137 Cr | ₹15,042 Cr | ₹12,416 Cr |
General Reserves | ₹813 Cr | ₹813 Cr | ₹813 Cr | ₹813 Cr | ₹813 Cr |
Other Reserves | ₹1,415 Cr | ₹685 Cr | ₹422 Cr | ₹411 Cr | ₹93 Cr |
Reserve excluding Revaluation Reserve | ₹26,781 Cr | ₹24,517 Cr | ₹21,871 Cr | ₹16,766 Cr | ₹13,832 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹26,840 Cr | ₹24,576 Cr | ₹21,930 Cr | ₹16,825 Cr | ₹13,891 Cr |
Minority Interest | ₹12 Cr | ₹-1.93 Cr | ₹-0.88 Cr | ₹0.14 Cr | ₹1.59 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹619 Cr | ₹249 Cr | ₹168 Cr | - | ₹49 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹619 Cr | ₹249 Cr | ₹168 Cr | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | ₹49 Cr |
Unsecured Loans | - | - | - | - | ₹131 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | ₹131 Cr |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-288 Cr | ₹122 Cr | ₹122 Cr | ₹128 Cr | ₹98 Cr |
Deferred Tax Assets | ₹769 Cr | ₹430 Cr | ₹601 Cr | ₹572 Cr | ₹613 Cr |
Deferred Tax Liability | ₹481 Cr | ₹552 Cr | ₹723 Cr | ₹700 Cr | ₹711 Cr |
Other Long Term Liabilities | ₹363 Cr | ₹360 Cr | ₹360 Cr | ₹352 Cr | ₹34 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹173 Cr | ₹172 Cr | ₹157 Cr | ₹75 Cr | ₹47 Cr |
Total Non-Current Liabilities | ₹867 Cr | ₹903 Cr | ₹807 Cr | ₹555 Cr | ₹358 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹3,871 Cr | ₹2,703 Cr | ₹2,795 Cr | ₹2,576 Cr | ₹2,552 Cr |
Sundry Creditors | ₹3,871 Cr | ₹2,703 Cr | ₹2,795 Cr | ₹2,576 Cr | ₹2,552 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹2,980 Cr | ₹3,107 Cr | ₹2,684 Cr | ₹2,875 Cr | ₹2,511 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹374 Cr | ₹562 Cr | ₹11 Cr | ₹21 Cr | ₹167 Cr |
Interest Accrued But Not Due | ₹0.79 Cr | - | - | ₹4.12 Cr | ₹0.39 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹2,605 Cr | ₹2,544 Cr | ₹2,674 Cr | ₹2,849 Cr | ₹2,343 Cr |
Short Term Borrowings | ₹4,230 Cr | ₹2,118 Cr | ₹4,804 Cr | ₹5,422 Cr | ₹6,573 Cr |
Secured ST Loans repayable on Demands | ₹1,927 Cr | ₹289 Cr | ₹885 Cr | ₹1,315 Cr | ₹1,629 Cr |
Working Capital Loans- Sec | ₹1,927 Cr | ₹289 Cr | ₹885 Cr | ₹1,315 Cr | ₹1,488 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹376 Cr | ₹1,540 Cr | ₹3,034 Cr | ₹2,792 Cr | ₹3,456 Cr |
Short Term Provisions | ₹412 Cr | ₹229 Cr | ₹382 Cr | ₹512 Cr | ₹385 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹212 Cr | ₹58 Cr | ₹210 Cr | ₹95 Cr | ₹66 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹201 Cr | ₹171 Cr | ₹172 Cr | ₹417 Cr | ₹318 Cr |
Total Current Liabilities | ₹11,494 Cr | ₹8,156 Cr | ₹10,665 Cr | ₹11,385 Cr | ₹12,021 Cr |
Total Liabilities | ₹39,213 Cr | ₹33,633 Cr | ₹33,401 Cr | ₹28,765 Cr | ₹26,271 Cr |
ASSETS | |||||
Gross Block | ₹18,593 Cr | ₹15,943 Cr | ₹13,613 Cr | ₹12,441 Cr | ₹10,498 Cr |
Less: Accumulated Depreciation | ₹7,570 Cr | ₹5,411 Cr | ₹4,240 Cr | ₹3,045 Cr | ₹2,023 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹11,024 Cr | ₹10,532 Cr | ₹9,374 Cr | ₹9,396 Cr | ₹8,475 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹4,496 Cr | ₹2,938 Cr | ₹2,429 Cr | ₹1,622 Cr | ₹1,342 Cr |
Non Current Investments | ₹392 Cr | ₹618 Cr | ₹431 Cr | ₹555 Cr | ₹360 Cr |
Long Term Investment | ₹392 Cr | ₹618 Cr | ₹431 Cr | ₹555 Cr | ₹360 Cr |
Quoted | ₹208 Cr | ₹318 Cr | ₹154 Cr | - | - |
Unquoted | ₹184 Cr | ₹301 Cr | ₹277 Cr | ₹555 Cr | ₹360 Cr |
Long Term Loans & Advances | ₹794 Cr | ₹575 Cr | ₹658 Cr | ₹378 Cr | ₹397 Cr |
Other Non Current Assets | ₹67 Cr | ₹38 Cr | ₹53 Cr | ₹37 Cr | ₹39 Cr |
Total Non-Current Assets | ₹17,667 Cr | ₹15,510 Cr | ₹13,578 Cr | ₹12,352 Cr | ₹10,939 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹151 Cr | ₹379 Cr | ₹160 Cr | ₹0.02 Cr | ₹0.02 Cr |
Quoted | ₹151 Cr | ₹379 Cr | ₹101 Cr | ₹0.02 Cr | ₹0.02 Cr |
Unquoted | - | ₹0.70 Cr | ₹60 Cr | ₹0.70 Cr | ₹0.70 Cr |
Inventories | ₹8,511 Cr | ₹7,554 Cr | ₹9,027 Cr | ₹7,700 Cr | ₹7,246 Cr |
Raw Materials | ₹2,681 Cr | ₹2,374 Cr | ₹3,028 Cr | ₹2,513 Cr | ₹2,397 Cr |
Work-in Progress | ₹1,407 Cr | ₹1,198 Cr | ₹1,302 Cr | ₹1,315 Cr | ₹1,355 Cr |
Finished Goods | ₹2,413 Cr | ₹2,095 Cr | ₹2,449 Cr | ₹2,066 Cr | ₹1,702 Cr |
Packing Materials | ₹378 Cr | ₹340 Cr | ₹355 Cr | ₹349 Cr | ₹337 Cr |
Stores Ā and Spare | ₹322 Cr | ₹292 Cr | ₹238 Cr | ₹174 Cr | ₹167 Cr |
Other Inventory | ₹1,309 Cr | ₹1,254 Cr | ₹1,655 Cr | ₹1,283 Cr | ₹1,288 Cr |
Sundry Debtors | ₹4,466 Cr | ₹4,012 Cr | ₹3,503 Cr | ₹4,315 Cr | ₹3,414 Cr |
Debtors more than Six months | ₹195 Cr | ₹205 Cr | ₹318 Cr | - | - |
Debtors Others | ₹4,393 Cr | ₹3,899 Cr | ₹3,280 Cr | ₹4,460 Cr | ₹3,495 Cr |
Cash and Bank | ₹6,084 Cr | ₹4,190 Cr | ₹5,474 Cr | ₹2,842 Cr | ₹1,957 Cr |
Cash in hand | ₹7.95 Cr | ₹7.79 Cr | ₹0.28 Cr | ₹0.35 Cr | ₹0.34 Cr |
Balances at Bank | ₹6,076 Cr | ₹4,182 Cr | ₹5,474 Cr | ₹2,842 Cr | ₹1,929 Cr |
Other cash and bank balances | - | - | - | - | ₹28 Cr |
Other Current Assets | ₹555 Cr | ₹394 Cr | ₹601 Cr | ₹489 Cr | ₹1,920 Cr |
Interest accrued on Investments | ₹15 Cr | ₹16 Cr | ₹9.40 Cr | ₹6.18 Cr | ₹4.63 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | - | - | - | - | - |
Other current_assets | ₹540 Cr | ₹378 Cr | ₹592 Cr | ₹483 Cr | ₹1,915 Cr |
Short Term Loans and Advances | ₹1,692 Cr | ₹1,515 Cr | ₹1,058 Cr | ₹1,066 Cr | ₹796 Cr |
Advances recoverable in cash or in kind | ₹490 Cr | ₹409 Cr | ₹333 Cr | ₹576 Cr | ₹225 Cr |
Advance income tax and TDS | ₹76 Cr | ₹270 Cr | ₹79 Cr | ₹16 Cr | ₹3.84 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹1,126 Cr | ₹836 Cr | ₹646 Cr | ₹474 Cr | ₹567 Cr |
Total Current Assets | ₹21,460 Cr | ₹18,044 Cr | ₹19,824 Cr | ₹16,413 Cr | ₹15,332 Cr |
Net Current Assets (Including Current Investments) | ₹9,966 Cr | ₹9,888 Cr | ₹9,158 Cr | ₹5,028 Cr | ₹3,312 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹39,213 Cr | ₹33,633 Cr | ₹33,401 Cr | ₹28,765 Cr | ₹26,271 Cr |
Contingent Liabilities | ₹159 Cr | ₹158 Cr | ₹141 Cr | ₹146 Cr | ₹134 Cr |
Total Debt | ₹4,862 Cr | ₹2,373 Cr | ₹4,972 Cr | ₹5,562 Cr | ₹6,967 Cr |
Book Value | 458.10 | 419.46 | 374.29 | 287.16 | 237.08 |
Adjusted Book Value | 458.10 | 419.46 | 374.29 | 287.16 | 237.08 |
Compare Balance Sheet of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹64,038.9 Cr | 6.4% | 0.8% | 117.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,001.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,813.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹100,075.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,325.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 6.4% |
0.8% |
117.4% |
SENSEX | 0.5% |
1.4% |
23.5% |
You may also like the below Video Courses